Phase 3 data support “changing the current standard of care to now include neoadjuvant and adjuvant pembrolizumab,” according to Ravindra Uppaluri, MD, PhD.

Researchers sought to determine whether dual-targeted CAR-T therapy would be effective for patients with relapsed or refractory MCL.

Addition of neoadjuvant and adjuvant pembrolizumab to standard care significantly improves event-free survival.

Colorectal Cancer Screening Scale is a gender-specific instrument developed and validated to assess for barriers to colorectal cancer screening among men.

Uterine cancer cases and deaths are projected to increase in Black women and White women in the United States.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

There was a shorter time between treatments in the preoperative SRT arm. Preoperative stereotactic radiation therapy (SRT) could expedite treatment for cancer patients with brain metastases and is as ...

SAD-CP, a home-based palliative care program, was shown to effectively meet the care needs of patients with advanced cancer, particularly in underserved areas.

Despite the increasing numbers of men seeking careers in nursing, persistent stereotypes and other barriers continue to limit ...

Researchers sought to determine whether CD26-positive leukemic stem cell levels could be used as a predictor of outcomes among patients with CML.

Twenty-one pathogenic variants found in clinically relevant genes, with an enrichment in mismatch repair genes.

HealthDay News — For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), according to a ...